ImageneBio, Inc. Earnings Per Share (Basic)
ImageneBio, Inc. (IMA) reported Earnings Per Share (Basic) of -$0.63 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- ImageneBio, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.63.
- ImageneBio, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.95.
- ImageneBio, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.86.
- ImageneBio, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$2.91.
- ImageneBio, Inc. earnings per share, basic for fiscal 2025 was -$9.64.
- ImageneBio, Inc. earnings per share, basic for fiscal 2024 was -$22.10.
- ImageneBio, Inc. earnings per share, basic for fiscal 2023 was -$1.63.
- ImageneBio, Inc. earnings per share, basic for fiscal 2022 was -$1.90.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.63 10-Q · filed 2026-08-05 | -$1.52 10-Q · filed 2026-08-05 | ||||||
| 2026-03-31 | -$0.95 10-Q · filed 2026-05-07 | -$1.82 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$4.66 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$2.83 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||||
| 2025-12-31 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-03-10 | -$3.92 derived: net income ÷ weighted average shares · filed 2026-03-10 | -$2.00 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$9.64 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | -$2.91 10-Q · filed 2025-11-12 | -$1.28 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$9.98 10-Q · filed 2025-11-12 | -$3.58 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||||
| 2025-06-30 | -$4.46 10-Q · filed 2026-08-05 | -$0.06 10-Q · filed 2025-07-24 | -$8.26 10-Q · filed 2026-08-05 | -$0.24 10-Q · filed 2025-07-24 | -$1.63 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$2.58 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||
| 2025-03-31 | -$3.80 10-Q · filed 2026-05-07 | -$0.18 10-Q · filed 2025-05-08 | -$12.05 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$16.47 derived: net income ÷ weighted average shares · filed 2026-05-07 | ||||
| 2024-12-31 | -$5.58 derived: net income ÷ weighted average shares · filed 2026-03-10 | -$9.99 derived: net income ÷ weighted average shares · filed 2026-03-10 | -$22.10 10-K · filed 2026-03-10 | -$1.02 10-K · filed 2025-03-06 | ||||
| 2024-09-30 | -$2.58 10-Q · filed 2025-11-12 | -$0.21 10-Q · filed 2024-11-07 | -$19.14 10-Q · filed 2025-11-12 | -$0.83 10-Q · filed 2024-11-07 | ||||
| 2024-06-30 | -$0.28 10-Q · filed 2025-07-24 | -$0.62 10-Q · filed 2025-07-24 | ||||||
| 2024-03-31 | -$0.33 10-Q · filed 2025-05-08 | |||||||
| 2023-12-31 | -$1.63 10-K · filed 2025-03-06 | |||||||
| 2023-09-30 | -$0.40 10-Q · filed 2024-11-07 | -$1.23 10-Q · filed 2024-11-07 | ||||||
| 2023-06-30 | -$0.44 10-Q · filed 2024-08-08 | -$0.83 10-Q · filed 2024-08-08 | ||||||
| 2023-03-31 | -$0.39 10-Q · filed 2024-05-13 | |||||||
| 2022-12-31 | -$1.90 10-K · filed 2024-03-12 | |||||||
| 2022-09-30 | -$0.48 10-Q · filed 2023-11-09 | -$1.51 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | -$0.57 10-Q · filed 2023-08-10 | -$1.03 10-Q · filed 2023-08-10 | ||||||
| 2022-03-31 | -$0.47 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | -$1.22 10-K · filed 2023-03-14 | |||||||
| 2021-09-30 | -$0.40 10-Q · filed 2022-11-07 | -$1.46 10-Q · filed 2022-11-07 | ||||||
| 2021-06-30 | -$0.35 10-Q · filed 2022-08-11 | -$1.12 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |